Immediate Impact
11 from Science/Nature 64 standout
Citing Papers
20-Year Risks of Breast-Cancer Recurrence after Stopping Endocrine Therapy at 5 Years
2017 Standout
Palbociclib and Letrozole in Advanced Breast Cancer
2016 Standout
Works of Michael W. DeGregorio being referenced
Selective estrogen receptor modulators inhibit growth and progression of premalignant lesions in a mouse model of ductal carcinoma in situ
2005
Effects of ospemifene and raloxifene on hormonal status, lipids, genital tract, and tolerability in postmenopausal women
2005
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| Michael W. DeGregorio | 1157 | 1047 | 753 | 97 | 3.0k | |
| Akihiro Sekine | 787 | 563 | 1527 | 103 | 4.3k | |
| Guanglin Cui | 719 | 992 | 967 | 124 | 3.8k | |
| Ellen M. Zimmermann | 1755 | 433 | 693 | 106 | 4.2k | |
| Ido Wolf | 860 | 1509 | 1465 | 154 | 4.1k | |
| Thomas Kirchner | 344 | 1236 | 901 | 117 | 4.4k | |
| Davide Serrano | 689 | 943 | 900 | 95 | 2.7k | |
| Andrea Fattorossi | 318 | 736 | 1059 | 141 | 3.4k | |
| Kate McKeage | 232 | 634 | 888 | 124 | 4.0k | |
| Heng Fan | 635 | 345 | 1048 | 102 | 3.1k | |
| Lawrence M. Solomon | 816 | 310 | 1271 | 90 | 4.0k |
All Works
Login with ORCID to disown or claim papers
Loading papers...